| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Evie Yulin CEO | IDX Exchange | ID1000136609 ISIN |
| Indonesia Country | 369 Employees | 8 Jun 2026 Last Dividend | 21 Dec 2015 Last Split | 23 Jul 1981 IPO Date |
PT Merck Tbk, established in 1970 and based in East Jakarta, Indonesia, is a prominent pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products within the Indonesian market. Operating through Biopharma, Consumer Health, and Others segments, PT Merck Tbk has a diverse portfolio that targets various health conditions. Initially known as PT Merck Indonesia Tbk until June 2002, the company has seen significant transformations over the years to better align with its market and operational strategies. As a subsidiary of Merck Holding GmbH, it benefits from a strong global network in the pharmaceutical industry, ensuring a steady flow of innovation and high-quality standards. PT Merck Tbk also extends its operations to office/property leasing and management, showcasing a diversified business model.
These include a range of drugs aimed at treating conditions related to the heart and blood vessels, as well as metabolic disorders. PT Merck Tbk offers innovative solutions to improve patient outcomes in diseases such as hypertension and diabetes.
PT Merck Tbk provides a portfolio of drugs for the treatment of various cancers, including colorectal cancer and head and neck cancer. These products are part of an extensive effort to combat the growing rate of cancer through effective treatments.
This category covers medicines for disorders like multiple sclerosis, addressing the needs of patients suffering from diseases that affect the brain and nerves.
These products cater to hormonal disorders, including growth hormone deficiencies, and issues related to infertility. PT Merck Tbk is involved in both the development and marketing of treatments to help individuals and couples facing these challenges.
The company offers a broad range of general medicines, covering various therapeutic areas. This includes treatments for thyroid disorders such as hyperthyroidism and hypothyroidism, ensuring a comprehensive approach to healthcare.
Beyond pharmaceuticals, PT Merck Tbk is engaged in office and property leasing and management, providing spaces for businesses and professionals. This diversifies its revenue streams and showcases the company's versatility in the marketplace.